EU Launched Investigation Into Chinese Aspirin Imports
Pharmaceutical distributors and medical buyers may face potential price hikes if new trade duties are imposed.
Updated on Sept. 23, 2026 in International Trade
Live Poll
Should the government impose trade duties to protect domestic industries from cheaper foreign imports?
The European Commission has initiated an anti-dumping investigation into Chinese acetylsalicylic acid imports following a complaint from French manufacturer Novacyl. The probe examines whether these imports have negatively impacted the European industry during the 2025-2026 period.
Why it matters
Operators in the medical supply chain should monitor this case, as anti-dumping investigations often precede the imposition of tariffs that raise procurement costs. The European Commission is currently assessing whether Chinese import trends have distorted the regional market for aspirin.
The probe covers the fiscal period from April 1, 2025, to March 31, 2026, comparing current import volumes and market share against preceding industry levels. The total volume of Chinese aspirin imports and the exact potential duty levels remain under investigation.
The players
European Commission
The executive branch of the European Union responsible for trade policy, including the enforcement of anti-dumping duties and market protections.
Novacyl
A French-based manufacturer of salicylic acid and derivatives, serving as the complainant in the investigation.
The details
The European Commission is evaluating evidence submitted by Novacyl to determine if imports from China have been sold at unfairly low prices, harming domestic production. If the investigation confirms dumping, the commission may implement definitive anti-dumping duties to protect the European industry. Businesses that rely on these specific chemical imports for manufacturing or distribution should prepare for potential supply chain disruptions or sudden cost increases.
Timeline
August 10, 2026: Novacyl lodged the formal complaint.
April 1, 2025 - March 31, 2026: The investigation covers this period.
September 23, 2026: The European Commission officially launched the investigation.
Market Landscape
This investigation follows the established procedure for the European Union's anti-dumping regulation enforcement framework. It mirrors similar sectoral trade defense measures typically triggered by domestic producers when foreign import market share surges.
Pharmaceutical wholesalers and manufacturers should stress-test their supply chains for potential cost increases on acetylsalicylic acid. Consult with customs brokers or legal counsel to monitor upcoming regulatory decisions that could trigger new import surcharges.
The takeaway
Anti-dumping probes are a leading indicator of potential cost shifts in specialized chemical commodities. Monitor the European Commission's trade portal for updates, as any resulting duties would apply directly to landed import costs for European firms.
Further reading
For broader trends in cross-border commerce, see the latest updates in International Trade.
More information
View the formal notice of initiation for details on the scope of the investigation.
Live Poll
Should the government impose trade duties to protect domestic industries from cheaper foreign imports?
